Luke M Beshar - Net Worth and Insider Trading
Luke M Beshar Net Worth
The estimated net worth of Luke M Beshar is at least $594,000 dollars as of 2024-05-11. Luke M Beshar is the Director of Protara Therapeutics Inc and owns about 198,000 shares of Protara Therapeutics Inc (TARA) stock worth over $594,000. Luke M Beshar is also the Director of Regenxbio Inc and owns about 0 shares of Regenxbio Inc (RGNX) stock worth over $0. Details can be seen in Luke M Beshar's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Luke M Beshar has not made any transactions after 2022-06-30 and currently still holds the listed stock(s).
Transaction Summary of Luke M Beshar
Luke M Beshar Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Luke M Beshar owns 3 companies in total, including Protara Therapeutics Inc (TARA) , Regenxbio Inc (RGNX) , and Omega Therapeutics Inc (OMGA) .
Click here to see the complete history of Luke M Beshar’s form 4 insider trades.
Insider Ownership Summary of Luke M Beshar
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
TARA | Protara Therapeutics Inc | 2022-06-30 | director |
RGNX | Regenxbio Inc | 2018-11-29 | director |
OMGA | Omega Therapeutics Inc | 2021-07-29 | director |
Luke M Beshar Latest Holdings Summary
Luke M Beshar currently owns a total of 2 stocks. Among these stocks, Luke M Beshar owns 198,000 shares of Protara Therapeutics Inc (TARA) as of June 30, 2022, with a value of $594,000 and a weighting of 100%. Luke M Beshar also owns 0 shares of Regenxbio Inc (RGNX) as of November 29, 2018, with a value of $0 and a weighting of 0%.
Latest Holdings of Luke M Beshar
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
TARA | Protara Therapeutics Inc | 2022-06-30 | 198,000 | 3.00 | 594,000 |
RGNX | Regenxbio Inc | 2018-11-29 | 0 | 15.44 | 0 |
Holding Weightings of Luke M Beshar
Luke M Beshar Form 4 Trading Tracker
According to the SEC Form 4 filings, Luke M Beshar has made a total of 3 transactions in Protara Therapeutics Inc (TARA) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Protara Therapeutics Inc is the acquisition of 10,000 shares on June 30, 2022, which cost Luke M Beshar around $31,000.
According to the SEC Form 4 filings, Luke M Beshar has made a total of 0 transactions in Regenxbio Inc (RGNX) over the past 5 years. The most-recent trade in Regenxbio Inc is the sale of 12,784 shares on November 29, 2018, which brought Luke M Beshar around $830,960.
Insider Trading History of Luke M Beshar
- 1
Luke M Beshar Trading Performance
GuruFocus tracks the stock performance after each of Luke M Beshar's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Luke M Beshar is -17.58%. GuruFocus also compares Luke M Beshar's trading performance to market benchmark return within the same time period. The performance of stocks bought by Luke M Beshar within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Luke M Beshar's insider trading performs compared to the benchmark.
Performance of Luke M Beshar
Luke M Beshar Ownership Network
Ownership Network List of Luke M Beshar
Ownership Network Relation of Luke M Beshar
Luke M Beshar Owned Company Details
What does Protara Therapeutics Inc do?
Who are the key executives at Protara Therapeutics Inc?
Luke M Beshar is the director of Protara Therapeutics Inc. Other key executives at Protara Therapeutics Inc include 10 percent owner Opaleye Management Inc. , Chief Financial Officer Patrick Fabbio , and director & CEO and President Jesse Shefferman .
Protara Therapeutics Inc (TARA) Insider Trades Summary
Over the past 18 months, Luke M Beshar made no insider transaction in Protara Therapeutics Inc (TARA). Other recent insider transactions involving Protara Therapeutics Inc (TARA) include a net sale of 197,773 shares made by Opaleye Management Inc. ,
In summary, during the past 3 months, insiders sold 182,300 shares of Protara Therapeutics Inc (TARA) in total and bought 0 shares, with a net sale of 182,300 shares. During the past 18 months, 197,773 shares of Protara Therapeutics Inc (TARA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 197,773 shares.
Protara Therapeutics Inc (TARA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Protara Therapeutics Inc Insider Transactions
Luke M Beshar Mailing Address
Above is the net worth, insider trading, and ownership report for Luke M Beshar. You might contact Luke M Beshar via mailing address: 550 Hills Drive, 3rd Floor, Bedminster Nj 07921.